AI assistant
Sending…
Moberg Pharma — Major Shareholding Notification 2017
Nov 22, 2017
3174_iss_2017-11-22_a78f249f-f5e0-4287-9c8a-99176910d230.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Moberg Pharma AB (publ)
Holder
195605 Staffan Persson
Instrument
| Instrument | Ordinary shares SE0003613090 |
|---|---|
| Before the transaction | |
| Shares | Data not given* |
| Voting rights | Data not given* |
| Transaction | |
| Reason for major shareholding notification Buy | |
| Date | 17/11/2017 |
| Limit for number of shares | 10 % |
| Limit for number of votes | 10 % |
| After the transaction | |
| Quantity | |
| Shares | 1,686,849 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 1,686,849 |
| Percentage | |
| Directly held shares | 9.672 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 9.672 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 9.672 % | 1,686,849 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 - Physically settled |
0.573 % | 100,000 |
| - Cash settled Total |
10.245 % | 1,786,849 |
| Chain of controlling companies |
| Voting rights % Voting rights Company | ||||
|---|---|---|---|---|
| 1,784,085 10.229 | Zimbrine Holding BV | |||
| 2,764 | 0.016 | Nortal Investments AB | ||
| Group total holdings | ||||
| Voting rights | 1,786,849 | |||
| Percentage of voting rights 10.245 |
Published
22/11/2017 14:25
| Contact | ||
|---|---|---|
| Name | Staffan Persson | |
| Phone | 0703210098 | Email [email protected] |
*Source of information has chosen not to submit the data
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Moberg Pharma
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 17
AGM Information
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 13